首页> 中文期刊> 《慢性疾病与转化医学(英文)》 >Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer:A review

Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer:A review

         

摘要

Gastric adenocarcinoma is one of the most common types of cancer worldwide, with an incidence of a million new cases annually. In addition to having a high mortality rate due to often delayed detection and its poor response to cancer therapy, it also spreads aggressively. Inflammation has been shown to play a role in carcinogenesis. Consequently, macrophages are important in phagocytosis, antigen presenting and producing cytokines and growth factors. As a response to microenvironmental signals, they may polarize into tumor resisting M1 or tumor promoting M2 macrophages. Recently, studies have indicated that M2-type macrophage resembling tumor-associated macrophages (TAMs) might be used as an independent prognostic factor for gastric cancer. This review will discuss the possible use of TAMs as prognostic tools for gastric cancer and whether they are suitable for use in clinical environment.

著录项

  • 来源
    《慢性疾病与转化医学(英文)》 |2018年第003期|156-163|共8页
  • 作者单位

    Department of Surgery, Helsinki University Hospital and University of Helsinki, Helsinki 00014, Finland;

    Department of Surgery, Helsinki University Hospital and University of Helsinki, Helsinki 00014, Finland;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号